Abstract
Aripiprazole, a D2 and 5-HT1A receptor partial agonist and 5-HT2A receptor, is an atypical antipsychotic. Previous studies indicated that the rate of extrapyramidal symptoms caused by aripiprazole is very close to that of placebo. However, there are studies and case reports in the literature describing aripiprazole-induced extrapyramidal symptoms. In this presented case, while using 10 mg/day of aripiprazole, severe parkinsonism appeared and theyd is appeared after discontinuation of the drug.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
